What is the most common treatment option for Gonococcal conjunctivitis?

What is the most common treatment option for Gonococcal conjunctivitis?

• A. Tobramycin
• B. Trimethoprim
• C. Moxifloxacin
• D. Ceftriaxone

Answer: (D)

Gonococcal conjunctivitis is a rapid, purulent infection caused by Neisseria gonorrhoeae, and it can involve or threaten deeper ocular structures. Because the organism can be aggressive and co-infection with Chlamydia trachomatis is common, the infection is treated with systemic antibiotics rather than relying on eye drops alone. A third-generation cephalosporin given systemically—ceftriaxone—is the recommended first-line option because it reliably covers gonococcus, including resistant strains, and addresses potential systemic spread. The typical approach is a single intramuscular dose of ceftriaxone, often combined with therapy for possible chlamydial co-infection (such as doxycycline for seven days, unless contraindicated). Topical antibiotics like tobramycin, trimethoprim, or moxifloxacin do not adequately treat the systemic component of the infection and are not sufficient as the primary treatment.

Gonococcal conjunctivitis is a rapid, purulent infection caused by Neisseria gonorrhoeae, and it can involve or threaten deeper ocular structures. Because the organism can be aggressive and co-infection with Chlamydia trachomatis is common, the infection is treated with systemic antibiotics rather than relying on eye drops alone. A third-generation cephalosporin given systemically—ceftriaxone—is the recommended first-line option because it reliably covers gonococcus, including resistant strains, and addresses potential systemic spread. The typical approach is a single intramuscular dose of ceftriaxone, often combined with therapy for possible chlamydial co-infection (such as doxycycline for seven days, unless contraindicated). Topical antibiotics like tobramycin, trimethoprim, or moxifloxacin do not adequately treat the systemic component of the infection and are not sufficient as the primary treatment.